1.

論文
論文
1. 脂肪肝から探る肥満症・２型糖尿病の病態
篁, 俊成
出版情報: 金沢大学十全医学会雑誌.  115  pp.99-103,  2006-06-01.  金沢大学十全医学会
URL: http://hdl.handle.net/2297/9767
2.

論文
論文
2. Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism
Karashima, Shigehiro ; Yoneda, Takashi ; Kometani, Mitsuhiro ; Ohe, Masashi ; Mori, Shunsuke ; Sawamura, Toshitaka ; Furukawa, Kenji ; Seta, Takashi ; Yamagishi, Masakazu ; Takeda, Yoshiyu
出版情報: Hypertension Research.  39  pp.133-137,  2016-03-01.  日本高血圧学会 = Japanese Society of Hypertension
URL: http://hdl.handle.net/2297/44875
概要: The mineralocorticoid receptor (MR) is expressed in the kidneys and in adipose tissue, and primary aldosteronism (PA) is … associated with metabolic syndrome. This study assessed the effects of MR blockade by eplerenone (EPL) and spironolactone (SPL) on blood pressure (BP) and metabolic factors in patients with PA. Fifty-four patients with PA were treated with one of two MRAs, EPL (25-100 mg daily, n=27) or SPL (12.5-100 mg daily, n=27) for 12 months. Visceral (VAT) and subcutaneous adipose tissue were quantified using CT and FatScan imaging analysis software. Body mass index, homeostasis model assessment-insulin resistance (HOMA-IR), serum creatinine, potassium and lipids, urinary albumin excretion (UAE) and plasma aldosterone concentration (PAC) and plasma renin activity (PRA) were measured before and after treatment. EPL and SPL decreased BP and increased serum potassium levels to similar degrees. PAC and PRA did not differ between the two groups. Although treatment with the MRAs did not change HOMA-IR or serum lipids, they significantly decreased UAE and VAT (P<0.05). These results suggest that EPL and SPL are effective and safe for the treatment of PA. The long-term metabolic and renal effects of these MRAs should be further investigated. © 2016 The Japanese Society of Hypertension. All rights reserved.<br />Embargo Period 6 months 続きを見る
3.

論文
論文
3. 脈波解析による動脈瘤診断手法の開発
大竹, 裕志 ; Ohtake, Hiroshi
出版情報: 平成20(2008)年度 科学研究費補助金 基盤研究(C) 研究成果報告書 = 2008 Fiscal Year Final Research Report.  2007 – 2008  pp.5p.-,  2009-05-07. 
URL: http://hdl.handle.net/2297/00059937
概要: 金沢大学附属病院<br />圧-流速曲線からの反射波計測により, 動脈の狭窄・拡張病変の存在を明らかにした, カテーテルを用いた侵襲的な測定法にかわる非侵襲的な圧測定と超音波による圧-流速曲線からの反射波計測の有用性を確立した.<br /> … 研究課題/領域番号:19591478, 研究期間(年度):2007 – 2008<br />出典：「脈波解析による動脈瘤診断手法の開発」研究成果報告書　課題番号19591478（KAKEN：科学研究費助成事業データベース（国立情報学研究所））（https://kaken.nii.ac.jp/ja/report/KAKENHI-PROJECT-19591478/19591478seika/)を加工して作成 続きを見る